)
Benitec Biopharma (BNTC) investor relations material
Benitec Biopharma Q2 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Focused on developing genetic medicines using a proprietary DNA-directed RNA interference (ddRNAi) platform, with lead candidate BB-301 for Oculopharyngeal Muscular Dystrophy (OPMD).
BB-301 has Orphan Drug Designation in the US and EU, and received Fast Track Designation from the FDA in November 2025; Phase 1b/2a trial ongoing with positive interim results and no severe adverse events reported.
Four patients in Cohort 1 of the BB-301 Phase 1b/2a study completed 12-month follow-up, all showing durable response, with Patient 1 demonstrating continued improvement at 24 months.
No products approved or revenue from product sales; operations funded through equity financing.
Financial highlights
Net loss of $11.8 million for the quarter and $20.8 million for the six months ended December 31, 2025, compared to $9.6 million and $14.6 million for the same periods in 2024.
Operating expenses rose to $13.4 million for the quarter and $23.2 million for the six months, driven by increased share-based compensation and salaries.
Cash and cash equivalents totaled $189 million as of December 31, 2025.
No outstanding borrowings or credit facilities.
Outlook and guidance
Cash position expected to fund operations for at least the next twelve months.
Continued operating losses anticipated as R&D and clinical activities progress.
Plans to engage with the FDA in mid-2026 to confirm pivotal study design for BB-301; interim Cohort 2 results expected mid-2026.
Next Benitec Biopharma earnings date
Next Benitec Biopharma earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)